IRIS Accounts Production v25.1.4.42 09222790 director 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092227902023-09-30092227902024-09-30092227902023-10-012024-09-30092227902022-09-30092227902022-10-012023-09-30092227902023-09-3009222790ns15:EnglandWales2023-10-012024-09-3009222790ns14:PoundSterling2023-10-012024-09-3009222790ns10:Director12023-10-012024-09-3009222790ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009222790ns10:SmallEntities2023-10-012024-09-3009222790ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3009222790ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3009222790ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3009222790ns10:FullAccounts2023-10-012024-09-3009222790ns10:OrdinaryShareClass12023-10-012024-09-3009222790ns10:RegisteredOffice2023-10-012024-09-3009222790ns5:CurrentFinancialInstruments2024-09-3009222790ns5:CurrentFinancialInstruments2023-09-3009222790ns5:ShareCapital2024-09-3009222790ns5:ShareCapital2023-09-3009222790ns5:RetainedEarningsAccumulatedLosses2024-09-3009222790ns5:RetainedEarningsAccumulatedLosses2023-09-3009222790ns5:PlantMachinery2023-10-012024-09-3009222790ns5:PlantMachinery2023-09-3009222790ns5:PlantMachinery2024-09-3009222790ns5:PlantMachinery2023-09-3009222790ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009222790ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3009222790ns5:AcceleratedTaxDepreciationDeferredTax2024-09-3009222790ns5:AcceleratedTaxDepreciationDeferredTax2023-09-3009222790ns5:DeferredTaxation2023-09-3009222790ns5:DeferredTaxation2024-09-3009222790ns10:OrdinaryShareClass12024-09-3009222790ns5:RetainedEarningsAccumulatedLosses2023-09-3009222790ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30092227901ns10:Director12023-09-30092227901ns10:Director12022-09-30092227901ns10:Director12023-10-012024-09-30092227901ns10:Director12022-10-012023-09-30092227901ns10:Director12024-09-30092227901ns10:Director12023-09-30
REGISTERED NUMBER: 09222790 (England and Wales)










Unaudited Financial Statements

for the Year Ended 30 September 2024

for

CLS HEALTHCARE COMMUNICATIONS LIMITED

CLS HEALTHCARE COMMUNICATIONS LIMITED (REGISTERED NUMBER: 09222790)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


CLS HEALTHCARE COMMUNICATIONS LIMITED

Company Information
for the Year Ended 30 September 2024







DIRECTOR: Ms C Scarborough





REGISTERED OFFICE: 35 Elvetham Road
Fleet
Hampshire
GU51 4QW





REGISTERED NUMBER: 09222790 (England and Wales)





ACCOUNTANTS: Adams Beeny Limited
4 Sudley Road
Bognor Regis
West Sussex
PO21 1EU

CLS HEALTHCARE COMMUNICATIONS LIMITED (REGISTERED NUMBER: 09222790)

Statement of Financial Position
30 September 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,103 2,006

CURRENT ASSETS
Debtors 5 24,489 22,062
Cash at bank 18,194 9,885
42,683 31,947
CREDITORS
Amounts falling due within one year 6 17,090 9,572
NET CURRENT ASSETS 25,593 22,375
TOTAL ASSETS LESS CURRENT
LIABILITIES

27,696

24,381

PROVISIONS FOR LIABILITIES 7 400 381
NET ASSETS 27,296 24,000

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 27,196 23,900
SHAREHOLDERS' FUNDS 27,296 24,000

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 June 2025 and were signed by:



Ms C Scarborough - Director


CLS HEALTHCARE COMMUNICATIONS LIMITED (REGISTERED NUMBER: 09222790)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

CLS Healthcare Communications Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the rate of invoiced amounts of technical writing services provided net of VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

CLS HEALTHCARE COMMUNICATIONS LIMITED (REGISTERED NUMBER: 09222790)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 5,382
Additions 798
At 30 September 2024 6,180
DEPRECIATION
At 1 October 2023 3,376
Charge for year 701
At 30 September 2024 4,077
NET BOOK VALUE
At 30 September 2024 2,103
At 30 September 2023 2,006

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade debtors 4,235 6,090
Other debtors 20,254 15,972
24,489 22,062

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Taxation and social security 17,090 9,572

7. PROVISIONS FOR LIABILITIES
30.9.24 30.9.23
£    £   
Deferred tax
Accelerated capital allowances 400 381

Deferred
tax
£   
Balance at 1 October 2023 381
Accelerated capital allowances 19
Balance at 30 September 2024 400

CLS HEALTHCARE COMMUNICATIONS LIMITED (REGISTERED NUMBER: 09222790)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
100 Ordinary 1 100 100

9. RESERVES
Retained
earnings
£   

At 1 October 2023 23,900
Profit for the year 48,296
Dividends (45,000 )
At 30 September 2024 27,196

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 September 2024 and 30 September 2023:

30.9.24 30.9.23
£    £   
Ms C Scarborough
Balance outstanding at start of year 15,931 4,858
Amounts advanced 62,025 63,937
Amounts repaid (57,750 ) (52,864 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 20,206 15,931

The loan with the director is interest free and repayable on demand.

11. ULTIMATE CONTROLLING PARTY

The controlling party is Ms C Scarborough.